GLOBAL BIOBUSINESS FRONTIER
GLOBAL BIOBUSINESS FRONTIER


Global market development & securing sustainable growth engine

At present, promoting business with 37 firms in 21 countries around the world





Pursue innovative new drugs development & sustainable growth

with early stage revenue stream

Mid-to-long-term sales U$ 3.5 b,

Operating profit U$ 1.7 b achieved in 2030!